HEADER TRANSFERASE/TRANSFERASE INHIBITOR 12-JUN-13 4L6S TITLE PARP COMPLEXED WITH BENZO[1,4]OXAZIN-3-ONE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 662-1011; COMPND 5 SYNONYM: PARP-1, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 1, COMPND 6 ARTD1, NAD(+) ADP-RIBOSYLTRANSFERASE 1, ADPRT 1, POLY[ADP-RIBOSE] COMPND 7 SYNTHASE 1; COMPND 8 EC: 2.4.2.30; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 STRAIN: BL21DE3; SOURCE 6 GENE: ADPRT, PARP 1, PARP1, PPOL; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DNA SINGLE-STRAND BREAK REPAIR SENSITIZE TUMORS, DNA REPAIR ENZYME, KEYWDS 2 DRD, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.R.DOUGAN,C.D.MOL,J.D.LAWSON REVDAT 4 28-FEB-24 4L6S 1 REMARK SEQADV REVDAT 3 24-JAN-18 4L6S 1 AUTHOR REVDAT 2 12-NOV-14 4L6S 1 AUTHOR REVDAT 1 07-AUG-13 4L6S 0 JRNL AUTH A.R.GANGLOFF,J.BROWN,R.DE JONG,D.R.DOUGAN,C.E.GRIMSHAW, JRNL AUTH 2 M.HIXON,A.JENNINGS,R.KAMRAN,A.KIRYANOV,S.O'CONNELL,E.TAYLOR, JRNL AUTH 3 P.VU JRNL TITL DISCOVERY OF NOVEL BENZO[B][1,4]OXAZIN-3(4H)-ONES AS JRNL TITL 2 POLY(ADP-RIBOSE)POLYMERASE INHIBITORS JRNL REF BIOORG.MED.CHEM.LETT. V. 23 4501 2013 JRNL REFN ISSN 0960-894X JRNL PMID 23850199 JRNL DOI 10.1016/J.BMCL.2013.06.055 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0025 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 3 NUMBER OF REFLECTIONS : 34271 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.167 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1814 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1603 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 61.18 REMARK 3 BIN R VALUE (WORKING SET) : 0.2110 REMARK 3 BIN FREE R VALUE SET COUNT : 110 REMARK 3 BIN FREE R VALUE : 0.2940 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5532 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 297 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.71000 REMARK 3 B22 (A**2) : 1.67000 REMARK 3 B33 (A**2) : -2.37000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.278 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.223 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.151 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.187 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.967 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5705 ; 0.012 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7702 ; 1.567 ; 1.991 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4 ; 1.172 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 700 ; 6.739 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 244 ;39.762 ;25.164 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1060 ;17.737 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;17.702 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 858 ; 0.104 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4226 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 2 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 662 A 1011 REMARK 3 RESIDUE RANGE : A 1100 A 1100 REMARK 3 ORIGIN FOR THE GROUP (A): 15.0155 -2.8832 -5.2222 REMARK 3 T TENSOR REMARK 3 T11: 0.0107 T22: 0.0538 REMARK 3 T33: 0.0192 T12: -0.0158 REMARK 3 T13: 0.0074 T23: -0.0008 REMARK 3 L TENSOR REMARK 3 L11: 0.2799 L22: 0.1046 REMARK 3 L33: 0.3253 L12: -0.0205 REMARK 3 L13: -0.1314 L23: 0.1021 REMARK 3 S TENSOR REMARK 3 S11: 0.0172 S12: 0.0125 S13: 0.0115 REMARK 3 S21: 0.0271 S22: -0.0353 S23: 0.0299 REMARK 3 S31: 0.0028 S32: 0.0453 S33: 0.0181 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 662 B 1011 REMARK 3 RESIDUE RANGE : B 1100 B 1100 REMARK 3 ORIGIN FOR THE GROUP (A): -6.0501 -20.4354 -38.1506 REMARK 3 T TENSOR REMARK 3 T11: 0.0271 T22: 0.0148 REMARK 3 T33: 0.0265 T12: 0.0019 REMARK 3 T13: -0.0044 T23: -0.0108 REMARK 3 L TENSOR REMARK 3 L11: 0.1468 L22: 0.1535 REMARK 3 L33: 0.7518 L12: -0.0397 REMARK 3 L13: -0.0115 L23: 0.3256 REMARK 3 S TENSOR REMARK 3 S11: 0.0245 S12: -0.0054 S13: -0.0416 REMARK 3 S21: -0.0237 S22: -0.0001 S23: -0.0092 REMARK 3 S31: -0.0539 S32: -0.0282 S33: -0.0243 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 4L6S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUL-13. REMARK 100 THE DEPOSITION ID IS D_1000080252. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAY-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9926 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35669 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 48.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.4M TRI-SODIUM CITRATE, 0.1M HEPES , REMARK 280 PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.26250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.59650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.52250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 82.59650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.26250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.52250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 659 REMARK 465 SER A 724 REMARK 465 GLY B 659 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 747 N - CA - C ANGL. DEV. = 17.9 DEGREES REMARK 500 ARG A 841 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 841 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 ARG B 841 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG B 841 NE - CZ - NH2 ANGL. DEV. = -4.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 662 -12.41 70.63 REMARK 500 SER A 663 127.52 75.47 REMARK 500 SER A 727 -73.93 -52.77 REMARK 500 LYS A 747 -135.65 31.39 REMARK 500 LYS A 748 91.46 95.26 REMARK 500 ASP A 914 90.67 -171.53 REMARK 500 ALA A 935 135.76 -38.95 REMARK 500 ASN A 980 -88.08 -73.37 REMARK 500 HIS B 826 54.33 -91.89 REMARK 500 LYS B 943 130.51 -37.92 REMARK 500 LEU B 964 87.06 -60.17 REMARK 500 ASP B 965 25.24 91.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MET A 746 LYS A 747 142.55 REMARK 500 LYS A 747 LYS A 748 -141.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1WQ A 1100 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1WQ B 1100 DBREF 4L6S A 662 1011 UNP P09874 PARP1_HUMAN 662 1011 DBREF 4L6S B 662 1011 UNP P09874 PARP1_HUMAN 662 1011 SEQADV 4L6S GLY A 659 UNP P09874 EXPRESSION TAG SEQADV 4L6S HIS A 660 UNP P09874 EXPRESSION TAG SEQADV 4L6S MET A 661 UNP P09874 EXPRESSION TAG SEQADV 4L6S ALA A 762 UNP P09874 VAL 762 ENGINEERED MUTATION SEQADV 4L6S GLY B 659 UNP P09874 EXPRESSION TAG SEQADV 4L6S HIS B 660 UNP P09874 EXPRESSION TAG SEQADV 4L6S MET B 661 UNP P09874 EXPRESSION TAG SEQADV 4L6S ALA B 762 UNP P09874 VAL 762 ENGINEERED MUTATION SEQRES 1 A 353 GLY HIS MET LYS SER LYS LEU PRO LYS PRO VAL GLN ASP SEQRES 2 A 353 LEU ILE LYS MET ILE PHE ASP VAL GLU SER MET LYS LYS SEQRES 3 A 353 ALA MET VAL GLU TYR GLU ILE ASP LEU GLN LYS MET PRO SEQRES 4 A 353 LEU GLY LYS LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SEQRES 5 A 353 SER ILE LEU SER GLU VAL GLN GLN ALA VAL SER GLN GLY SEQRES 6 A 353 SER SER ASP SER GLN ILE LEU ASP LEU SER ASN ARG PHE SEQRES 7 A 353 TYR THR LEU ILE PRO HIS ASP PHE GLY MET LYS LYS PRO SEQRES 8 A 353 PRO LEU LEU ASN ASN ALA ASP SER VAL GLN ALA LYS ALA SEQRES 9 A 353 GLU MET LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SEQRES 10 A 353 SER LEU LEU ARG GLY GLY SER ASP ASP SER SER LYS ASP SEQRES 11 A 353 PRO ILE ASP VAL ASN TYR GLU LYS LEU LYS THR ASP ILE SEQRES 12 A 353 LYS VAL VAL ASP ARG ASP SER GLU GLU ALA GLU ILE ILE SEQRES 13 A 353 ARG LYS TYR VAL LYS ASN THR HIS ALA THR THR HIS ASN SEQRES 14 A 353 ALA TYR ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU SEQRES 15 A 353 ARG GLU GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN SEQRES 16 A 353 LEU HIS ASN ARG ARG LEU LEU TRP HIS GLY SER ARG THR SEQRES 17 A 353 THR ASN PHE ALA GLY ILE LEU SER GLN GLY LEU ARG ILE SEQRES 18 A 353 ALA PRO PRO GLU ALA PRO VAL THR GLY TYR MET PHE GLY SEQRES 19 A 353 LYS GLY ILE TYR PHE ALA ASP MET VAL SER LYS SER ALA SEQRES 20 A 353 ASN TYR CYS HIS THR SER GLN GLY ASP PRO ILE GLY LEU SEQRES 21 A 353 ILE LEU LEU GLY GLU VAL ALA LEU GLY ASN MET TYR GLU SEQRES 22 A 353 LEU LYS HIS ALA SER HIS ILE SER LYS LEU PRO LYS GLY SEQRES 23 A 353 LYS HIS SER VAL LYS GLY LEU GLY LYS THR THR PRO ASP SEQRES 24 A 353 PRO SER ALA ASN ILE SER LEU ASP GLY VAL ASP VAL PRO SEQRES 25 A 353 LEU GLY THR GLY ILE SER SER GLY VAL ASN ASP THR SER SEQRES 26 A 353 LEU LEU TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN SEQRES 27 A 353 VAL ASN LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE SEQRES 28 A 353 LYS THR SEQRES 1 B 353 GLY HIS MET LYS SER LYS LEU PRO LYS PRO VAL GLN ASP SEQRES 2 B 353 LEU ILE LYS MET ILE PHE ASP VAL GLU SER MET LYS LYS SEQRES 3 B 353 ALA MET VAL GLU TYR GLU ILE ASP LEU GLN LYS MET PRO SEQRES 4 B 353 LEU GLY LYS LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SEQRES 5 B 353 SER ILE LEU SER GLU VAL GLN GLN ALA VAL SER GLN GLY SEQRES 6 B 353 SER SER ASP SER GLN ILE LEU ASP LEU SER ASN ARG PHE SEQRES 7 B 353 TYR THR LEU ILE PRO HIS ASP PHE GLY MET LYS LYS PRO SEQRES 8 B 353 PRO LEU LEU ASN ASN ALA ASP SER VAL GLN ALA LYS ALA SEQRES 9 B 353 GLU MET LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SEQRES 10 B 353 SER LEU LEU ARG GLY GLY SER ASP ASP SER SER LYS ASP SEQRES 11 B 353 PRO ILE ASP VAL ASN TYR GLU LYS LEU LYS THR ASP ILE SEQRES 12 B 353 LYS VAL VAL ASP ARG ASP SER GLU GLU ALA GLU ILE ILE SEQRES 13 B 353 ARG LYS TYR VAL LYS ASN THR HIS ALA THR THR HIS ASN SEQRES 14 B 353 ALA TYR ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU SEQRES 15 B 353 ARG GLU GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN SEQRES 16 B 353 LEU HIS ASN ARG ARG LEU LEU TRP HIS GLY SER ARG THR SEQRES 17 B 353 THR ASN PHE ALA GLY ILE LEU SER GLN GLY LEU ARG ILE SEQRES 18 B 353 ALA PRO PRO GLU ALA PRO VAL THR GLY TYR MET PHE GLY SEQRES 19 B 353 LYS GLY ILE TYR PHE ALA ASP MET VAL SER LYS SER ALA SEQRES 20 B 353 ASN TYR CYS HIS THR SER GLN GLY ASP PRO ILE GLY LEU SEQRES 21 B 353 ILE LEU LEU GLY GLU VAL ALA LEU GLY ASN MET TYR GLU SEQRES 22 B 353 LEU LYS HIS ALA SER HIS ILE SER LYS LEU PRO LYS GLY SEQRES 23 B 353 LYS HIS SER VAL LYS GLY LEU GLY LYS THR THR PRO ASP SEQRES 24 B 353 PRO SER ALA ASN ILE SER LEU ASP GLY VAL ASP VAL PRO SEQRES 25 B 353 LEU GLY THR GLY ILE SER SER GLY VAL ASN ASP THR SER SEQRES 26 B 353 LEU LEU TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN SEQRES 27 B 353 VAL ASN LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE SEQRES 28 B 353 LYS THR HET 1WQ A1100 26 HET 1WQ B1100 26 HETNAM 1WQ (2S)-6-{[4-(4-CHLOROPHENYL)-3,6-DIHYDROPYRIDIN-1(2H)- HETNAM 2 1WQ YL]METHYL}-2-METHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE FORMUL 3 1WQ 2(C21 H21 CL N2 O2) FORMUL 5 HOH *297(H2 O) HELIX 1 1 PRO A 666 PHE A 677 1 12 HELIX 2 2 ASP A 678 TYR A 689 1 12 HELIX 3 3 PRO A 697 LEU A 701 5 5 HELIX 4 4 SER A 702 GLN A 722 1 21 HELIX 5 5 ASP A 726 ILE A 740 1 15 HELIX 6 6 ASN A 754 GLY A 780 1 27 HELIX 7 7 ASP A 788 LEU A 797 1 10 HELIX 8 8 SER A 808 THR A 821 1 14 HELIX 9 9 ALA A 823 ASN A 827 5 5 HELIX 10 10 GLY A 843 LYS A 849 1 7 HELIX 11 11 PRO A 850 LYS A 852 5 3 HELIX 12 12 ARG A 865 THR A 867 5 3 HELIX 13 13 ASN A 868 GLY A 876 1 9 HELIX 14 14 PRO A 885 TYR A 889 5 5 HELIX 15 15 MET A 900 ASN A 906 1 7 HELIX 16 16 TYR A 907 HIS A 909 5 3 HELIX 17 17 PRO A 958 ASN A 961 5 4 HELIX 18 18 ASP A 993 ALA A 995 5 3 HELIX 19 19 PRO B 666 PHE B 677 1 12 HELIX 20 20 ASP B 678 TYR B 689 1 12 HELIX 21 21 PRO B 697 LEU B 701 5 5 HELIX 22 22 SER B 702 GLY B 723 1 22 HELIX 23 23 SER B 725 ILE B 740 1 16 HELIX 24 24 ASN B 754 GLY B 780 1 27 HELIX 25 25 ASP B 788 LEU B 797 1 10 HELIX 26 26 SER B 808 THR B 821 1 14 HELIX 27 27 GLY B 843 GLN B 853 1 11 HELIX 28 28 ARG B 865 THR B 867 5 3 HELIX 29 29 ASN B 868 GLY B 876 1 9 HELIX 30 30 PRO B 885 TYR B 889 5 5 HELIX 31 31 MET B 900 TYR B 907 1 8 HELIX 32 32 PRO B 958 ASN B 961 5 4 HELIX 33 33 ASP B 993 ALA B 995 5 3 SHEET 1 A 5 THR A 799 VAL A 803 0 SHEET 2 A 5 TYR A 829 ARG A 841 -1 O LYS A 838 N LYS A 802 SHEET 3 A 5 VAL A 997 PHE A1009 -1 O LYS A1004 N ILE A 834 SHEET 4 A 5 ILE A 916 ALA A 925 -1 N ILE A 919 O LEU A1003 SHEET 5 A 5 ARG A 857 SER A 864 -1 N HIS A 862 O LEU A 920 SHEET 1 B 4 ILE A 895 PHE A 897 0 SHEET 2 B 4 GLU A 988 VAL A 991 -1 O VAL A 991 N ILE A 895 SHEET 3 B 4 SER A 947 GLY A 950 -1 N VAL A 948 O ILE A 990 SHEET 4 B 4 MET A 929 LEU A 932 1 N TYR A 930 O SER A 947 SHEET 1 C 3 GLY A 974 SER A 976 0 SHEET 2 C 3 GLY A 952 PRO A 956 -1 N THR A 955 O ILE A 975 SHEET 3 C 3 LEU A 984 TYR A 986 1 O LEU A 985 N THR A 954 SHEET 1 D 2 ILE A 962 LEU A 964 0 SHEET 2 D 2 VAL A 967 VAL A 969 -1 O VAL A 969 N ILE A 962 SHEET 1 E 5 THR B 799 VAL B 803 0 SHEET 2 E 5 TYR B 829 ARG B 841 -1 O LYS B 838 N LYS B 802 SHEET 3 E 5 VAL B 997 PHE B1009 -1 O LEU B1002 N PHE B 837 SHEET 4 E 5 ILE B 916 ALA B 925 -1 N GLU B 923 O ASN B 998 SHEET 5 E 5 ARG B 857 SER B 864 -1 N ARG B 858 O VAL B 924 SHEET 1 F 4 ILE B 895 PHE B 897 0 SHEET 2 F 4 GLU B 988 VAL B 991 -1 O VAL B 991 N ILE B 895 SHEET 3 F 4 SER B 947 GLY B 950 -1 N VAL B 948 O ILE B 990 SHEET 4 F 4 MET B 929 LEU B 932 1 N LEU B 932 O LYS B 949 SHEET 1 G 2 THR B 954 PRO B 956 0 SHEET 2 G 2 GLY B 974 SER B 976 -1 O ILE B 975 N THR B 955 SITE 1 AC1 12 ASP A 766 ASN A 767 LEU A 769 ASP A 770 SITE 2 AC1 12 HIS A 862 GLY A 863 ARG A 878 ALA A 880 SITE 3 AC1 12 TYR A 896 SER A 904 TYR A 907 HOH A1246 SITE 1 AC2 10 ASP B 766 ASN B 767 ASP B 770 HIS B 862 SITE 2 AC2 10 GLY B 863 ARG B 878 TYR B 896 PHE B 897 SITE 3 AC2 10 SER B 904 TYR B 907 CRYST1 48.525 93.045 165.193 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020608 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010747 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006054 0.00000